sr 48692 has been researched along with Carcinoma, Small Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casibang, M; Chan, D; Chiles, J; Davis, TP; Moody, E; Moody, TW | 1 |
1 other study(ies) available for sr 48692 and Carcinoma, Small Cell
| Article | Year |
|---|---|
SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
Topics: Animals; Carcinoma, Small Cell; Cell Division; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pyrazoles; Quinolines; Receptors, Neurotensin; Signal Transduction; Tumor Cells, Cultured | 2001 |